Gapping upIn reaction to earnings/guidance:
- TCBI +3.9%, EGBN +1.6%, SMCI +1.4% (DecQ guidance), THC +1% (guidance), WNS +0.7%
Other news:
- VMEO +4.2% (reports December 2022 statistics)
- BLUE +3.6% (prices offering of 20 mln shares of common stock at $6.00 per share)
- CHK +2.4% (to sell Brazos Valley region)
- TCMD +1.4% (files $150 mln mixed shelf)
- EDIT +1.4% (Editas Medicine and Shoreline Biosciences enter into definitive agreement for Shoreline to Acquire Editas' iNK cell franchise and related gene editing technologies)
- BSM +1.2% (CFO departing)
- PSNL +1.2% (approved a reduction in the Company's workforce by up to approximately 30% to reduce operating costs and improve operating efficiency)
- PGTI +1% (collaborating with GLW)
Analyst comments:
- CVAC +9.7% (upgraded to Buy from Neutral at UBS)